Cancer Patients

Oncology·MeSH: Neoplasms

19 drugs in development·11 companies·2 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
subsys	Insys Therapeutics, Inc. (INSY)

Phase 3(3)

Drug	Company
aglatimagene besadenovec + valacyclovir	Candel Therapeutics, Inc. (CADL)
Amivantamab + FOLFIRI	IGM Biosciences, Inc. (IGMS)
treatment arm	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)

Phase 2(11)

Drug	Company
Adagrasib	Amneal Pharmaceuticals, Inc. (AMRX)
Amivantamab	IGM Biosciences, Inc. (IGMS)
Amivantamab IV	IGM Biosciences, Inc. (IGMS)
Cabozantinib	PTC THERAPEUTICS, INC. (PTCT)
Daratumumab	PTC THERAPEUTICS, INC. (PTCT)
Enzalutamide	PTC THERAPEUTICS, INC. (PTCT)
EOS-448	iTeos Therapeutics, Inc. (ITOS)
Regorafinib	PTC THERAPEUTICS, INC. (PTCT)
Relatlimab	PTC THERAPEUTICS, INC. (PTCT)
Rucaparib	PTC THERAPEUTICS, INC. (PTCT)
Trametinib	PTC THERAPEUTICS, INC. (PTCT)

Preclinical(1)

Drug	Company
CD38-Diagnostic	Coeptis Therapeutics Holdings Inc. (COEP)

Phase 1/Phase 2(2)

Drug	Company
ABV-1601	ABVC BIOPHARMA, INC. (ABVC)
ATR-04	Azitra, Inc. (AZTR)

Phase 2/Phase 3(1)

Drug	Company
utidelone	BIOSTAR PHARMACEUTICALS, INC. (BSPM)

BioSniper tracks 19 drugs in development for Cancer Patients across 11 companies.

There are 2 clinical trials targeting Cancer Patients tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.